The abstract is read at the publisher; the summary is JClub's.
PfHsp90 inhibition in Plasmodium falciparum blood-stage parasites reduces parasite DNA content and nascent DNA synthesis, linking PfHsp90 activity to DNA replication.
- Why it matters: PfHsp90 is a promising antimalarial target, yet the specific molecular pathways it supports in parasite development are not well defined.
- What they did: Using geldanamycin and XL888, the PfHsp90-dependent proteome was profiled in blood stage, yielding 131 proteins reduced by both treatments, with 40% co-immunoprecipitating with PfHsp90.
- The result: DNA replication was the most enriched pathway, and PfHsp90 inhibition lowered DNA content and nascent DNA synthesis in both blood- and liver-stage development; pairing with DNA replication inhibitors produced synergistic antiparasitic activity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.